Pancreatic Cancer section

Prostate Cancer News & Features

Prostate-Specific Antigen (PSA) Test (Fact Sheet)

Prostate-Specific Antigen (PSA) Test (Fact Sheet)

This fact sheet reviews the PSA test for prostate cancer, in particular screening recommendations, test limitations, and possible improvements the future may hold in store for the test.

Rates of Nonrecommended Screenings for Prostate and Breast Cancers Is High Among Older Patients

Among persons 65 years or older with limited life expectancies of less than 10 years, an estimated 15.7% may have undergone nonrecommended screenings for prostate and breast cancers.

CRPC: Enzalutamide Better Than Bicalutamide for Improving PFS

CRPC: Enzalutamide Better Than Bicalutamide for Improving PFS

Enzalutamide significantly reduced the risk of prostate cancer progression or death in prostate cancer.

Some Improvements in Survival, Skeletal Events Seen in Clinical Trial of Docetaxel Combo

Some Improvements in Survival, Skeletal Events Seen in Clinical Trial of Docetaxel Combo

Phase 3 results of the TRAPEZE trial of patients with bony metastatic castrate-refractory prostate cancer (CRPC).

Lethal Prostate Cancer Risk Lower With Regular Aspirin Use

Lethal Prostate Cancer Risk Lower With Regular Aspirin Use

The risk of lethal prostate cancer, but not of overall, high-grade, or advanced cancers, was reduced with regular aspirin use.

Prostate Cancer Videos

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs